Prevention and management of dermatological toxicities related to anticancer agents: ESMO clinical practice guidelines☆
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
Annals of oncology
Year: 2020, Jahrgang: 32, Heft: 2, Pages: 157-170 |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/j.annonc.2020.11.005 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.annonc.2020.11.005 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753420431576 |
| Verfasserangaben: | M.E. Lacouture, V. Sibaud, P.A. Gerber, C. van den Hurk, P. Fernández-Peñas, D. Santini, F. Jahn & K. Jordan, on behalf of the ESMO Guidelines Committee |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1750821753 | ||
| 003 | DE-627 | ||
| 005 | 20230426083819.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210309r20212020xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.annonc.2020.11.005 |2 doi | |
| 035 | |a (DE-627)1750821753 | ||
| 035 | |a (DE-599)KXP1750821753 | ||
| 035 | |a (OCoLC)1341398293 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lacouture, Mario E. |e VerfasserIn |0 (DE-588)1047565242 |0 (DE-627)778564797 |0 (DE-576)401167852 |4 aut | |
| 245 | 1 | 0 | |a Prevention and management of dermatological toxicities related to anticancer agents |b ESMO clinical practice guidelines☆ |c M.E. Lacouture, V. Sibaud, P.A. Gerber, C. van den Hurk, P. Fernández-Peñas, D. Santini, F. Jahn & K. Jordan, on behalf of the ESMO Guidelines Committee |
| 264 | 1 | |c 2021 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 25 November 2020 | ||
| 500 | |a Gesehen am 09.03.2021 | ||
| 534 | |c 2020 | ||
| 650 | 4 | |a acneiform rash | |
| 650 | 4 | |a chemotherapy-induced alopecia | |
| 650 | 4 | |a dermatological toxicities | |
| 650 | 4 | |a drug-induced pruritus | |
| 650 | 4 | |a hand-foot syndrome | |
| 650 | 4 | |a Supportive care | |
| 700 | 1 | |a Sibaud, V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gerber, P. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a van den Hurk, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fernández-Peñas, P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Santini, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jahn, F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jordan, Karin |d 1974- |e VerfasserIn |0 (DE-588)123243327 |0 (DE-627)706224078 |0 (DE-576)293619174 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 32(2021), 2, Seite 157-170 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Prevention and management of dermatological toxicities related to anticancer agents ESMO clinical practice guidelines☆ |
| 773 | 1 | 8 | |g volume:32 |g year:2021 |g number:2 |g pages:157-170 |g extent:14 |a Prevention and management of dermatological toxicities related to anticancer agents ESMO clinical practice guidelines☆ |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.annonc.2020.11.005 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0923753420431576 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210309 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 123243327 |a Jordan, Karin |m 123243327:Jordan, Karin |d 910000 |d 910100 |e 910000PJ123243327 |e 910100PJ123243327 |k 0/910000/ |k 1/910000/910100/ |p 8 |y j | ||
| 999 | |a KXP-PPN1750821753 |e 3883027766 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"origin":[{"dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990"}],"language":["eng"],"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"id":{"issn":["1569-8041"],"zdb":["2003498-2"],"eki":["320428796"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology"}],"part":{"year":"2021","extent":"14","issue":"2","volume":"32","pages":"157-170","text":"32(2021), 2, Seite 157-170"},"disp":"Prevention and management of dermatological toxicities related to anticancer agents ESMO clinical practice guidelines☆Annals of oncology","recId":"320428796","pubHistory":["1.1990 -"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"]}],"title":[{"title_sort":"Prevention and management of dermatological toxicities related to anticancer agents","title":"Prevention and management of dermatological toxicities related to anticancer agents","subtitle":"ESMO clinical practice guidelines☆"}],"person":[{"role":"aut","given":"Mario E.","display":"Lacouture, Mario E.","family":"Lacouture"},{"role":"aut","given":"V.","display":"Sibaud, V.","family":"Sibaud"},{"role":"aut","given":"P. A.","family":"Gerber","display":"Gerber, P. A."},{"given":"C.","display":"van den Hurk, C.","family":"van den Hurk","role":"aut"},{"role":"aut","display":"Fernández-Peñas, P.","family":"Fernández-Peñas","given":"P."},{"role":"aut","given":"D.","display":"Santini, D.","family":"Santini"},{"given":"F.","family":"Jahn","display":"Jahn, F.","role":"aut"},{"role":"aut","given":"Karin","family":"Jordan","display":"Jordan, Karin"}],"physDesc":[{"extent":"14 S."}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1750821753"],"doi":["10.1016/j.annonc.2020.11.005"]},"language":["eng"],"note":["Available online 25 November 2020","Gesehen am 09.03.2021"],"recId":"1750821753","name":{"displayForm":["M.E. Lacouture, V. Sibaud, P.A. Gerber, C. van den Hurk, P. Fernández-Peñas, D. Santini, F. Jahn & K. Jordan, on behalf of the ESMO Guidelines Committee"]}} | ||
| SRT | |a LACOUTUREMPREVENTION2021 | ||